FOXM1 and hepatocellular carcinoma: Given our novel observation of re-sensitization of resistant HCC cells to Artemisinin therapy following FoxM1 depletion, the efficacy of contemporary chemotherapeutic regimes is expected to improve in presence of FoxM1 inhibitors.